Journal Papers

Some of our teams have gone on to publish their work in journals. Take a look at some of our published research - we hope you'll enjoy what we've produced so far! Authors labelled in bold and underlined are Polygeia researchers/editors!

2020

Mulchandani. R,  Power, H.S & Cavallaro, F.L. (2020) The influence of individual provider characteristics and attitudes on caesarean section decision-making: a global review, Journal of Obstetrics and Gynaecology, 40:1, 1-9, DOI: 10.1080/01443615.2019.1587603

Abstract

Caesarean section (CS) rates have risen worldwide in the past two decades, particularly in middle and high-income countries. In addition to changing maternal and health system factors, there is growing evidence that provider factors may contribute to rising unnecessary caesareans. The aim of this review was to assess the evidence for the association between individual provider characteristics, attitudes towards CS and decision-making for CS. A search was conducted in May 2018 in PubMed and Web of Science with 23 papers included in our final review. Our results show that higher anxiety scores and more favourable opinions of CS were associated with increased likelihood of performing CS. These findings highlight a need for appropriate interventions to target provider attitudes towards CS to reduce unnecessary procedures.

2019

Caulfield A, Vatansever D, Lambert G, Van Boatel, T. (2019). WHO guidance on mental health training: a systematic review of the progress for non-specialist health workers. BMJ Open 2019;9:e024059. doi:10.1136/ bmjopen-2018-024059

Abstract

Training non-specialist workers in mental healthcare is an effective strategy to increase global provision and capacity, and improves knowledge, attitude, skill and confidence among health workers, as well as clinical practice and patient outcome. Areas for future focus include the development of standardised evaluation methods and outcomes to allow cross-comparison between studies, and optimisation of course structure. In this study, the researchers assessed existing literature on the effectiveness of mental health training courses for non-specialist health workers, based on the WHO guidelines (2008).

2018

Aldridge, R.W., Nellums, L.B., Bartlett, S., Barr, A.L., Patel, P., Burns, R., Hargreaves, S., Miranda, J.J., Tollman, S., Friedland, J.S. and Abubakar, I., 2018. Global patterns of mortality in international migrants: a systematic review and meta-analysis. The Lancet, 392 (10164), pp.2553-2566.

Abstract

258 million people reside outside their country of birth; however, to date no global systematic reviews or meta-analyses of mortality data for these international migrants have been done. We aimed to review and synthesise available mortality data on international migrants.

2017

Kazzazi, F., Pollard, C., Tern, P., Ayuso-Garcia, A., Gillespie, J. and Thomsen, I. (2017). Evaluating the impact of Brexit on the pharmaceutical industry. Journal of Pharmaceutical Policy and Practice, 10(1).

Abstract

The UK Pharmaceutical Industry is arguably one of the most important industries to consider in the negotiations following the Brexit vote. Providing tens of thousands of jobs and billions in tax revenue and research investment, the importance of this industry cannot be understated. At stake is the global leadership in the sector, which produces some of the field's most influential basic science and translation work. However, interruptions and losses may occur at multiple levels, affecting patients, researchers, universities, companies and government.With thorough investigation of the literature, we propose four foundations in the advancement of negotiations. These prioritise: negotiation of 'associated country' status, bilaterally favourable trade agreements, minimal interruption to regulatory bodies and special protection for the movement of workforce in the life sciences industry.

2016

Mi, E., Mi, E. and Jeggo, M. (2016). Where to Now for One Health and Ecohealth?. EcoHealth, 13(1), pp.12-17.

Abstract

Whilst subdivided and with complex interactive origins, two broad groups, One Health and Ecohealth, currently characterise global efforts to tackle the health of people, animals and our environment. One Health and Ecohealth have much in common conceptually in the issues they address (although they differ in their emphasis) and institutionally in their emphasis on interdisciplinary collaboration, but both suffer from limited resources and support. We explore the possibilities for further convergence or unity.

Hamilton, W. L., Doyle, C., Halliwell-Ewen, M., & Lambert, G. (2016). Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies. Health policy and planning, 31(10), 1448-1466.

Abstract

Background: Falsified medicines are deliberately fraudulent drugs that pose a direct risk to patient health and undermine healthcare systems, causing global morbidity and mortality.

Objective: To produce an overview of anti-falsifying public health interventions deployed at international, national and local scales in low and middle income countries (LMIC).

Data sources: We conducted a systematic search of the PubMed, Web of Science, Embase and Cochrane Central Register of Controlled Trials databases for healthcare or pharmaceutical policies relevant to reducing the burden of falsified medicines in LMIC.

Results: Our initial search identified 660 unique studies, of which 203 met title/abstract inclusion criteria and were categorised according to their primary focus: international; national; local pharmacy; internet pharmacy; drug analysis tools. Eighty-four were included in the qualitative synthesis, along with 108 articles and website links retrieved through secondary searches.

Discussion: On the international stage, we discuss the need for accessible pharmacovigilance (PV) global reporting systems, international leadership and funding incorporating multiple stakeholders (healthcare, pharmaceutical, law enforcement) and multilateral trade agreements that emphasise public health. On the national level, we explore the importance of establishing adequate medicine regulatory authorities and PV capacity, with drug screening along the supply chain. This requires interdepartmental coordination, drug certification and criminal justice legislation and enforcement that recognise the severity of medicine falsification. Local healthcare professionals can receive training on medicine quality assessments, drug registration and pharmacological testing equipment. Finally, we discuss novel technologies for drug analysis which allow rapid identification of fake medicines in low-resource settings. Innovative point-of-purchase systems like mobile phone verification allow consumers to check the authenticity of their medicines.

Conclusions: Combining anti-falsifying strategies targeting different levels of the pharmaceutical supply chain provides multiple barriers of protection from falsified medicines. This requires the political will to drive policy implementation; otherwise, people around the world remain at risk.

Subscribe to Mailing List
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

© 2019 by Polygeia.        Privacy Policy • Cookie Policy